Join
Live feed
·
INSIDERFilingvia Quantisnow
Crinetics Pharmaceuticals Inc. logo

Director Deardorf Caren returned $1,889,125 worth of shares to the company (22,225 units at $85.00), closing all direct ownership in the company (SEC Form 4) to cover taxes

ByQuantisnow·Wall Street's wire, on your screen.
CRNX· Crinetics Pharmaceuticals Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CRNX (Crinetics Pharmaceuticals Inc.) and more on Quantisnow.